Vita Life Sciences Ltd
ASX:VLS
Vita Life Sciences Ltd
Revenue
Vita Life Sciences Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vita Life Sciences Ltd
ASX:VLS
|
Revenue
AU$74.2m
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
8%
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Revenue
AU$190.3m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Revenue
AU$237.6m
|
CAGR 3-Years
550%
|
CAGR 5-Years
77%
|
CAGR 10-Years
47%
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Revenue
AU$588.4k
|
CAGR 3-Years
56%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Probiotec Ltd
ASX:PBP
|
Revenue
AU$221.2m
|
CAGR 3-Years
28%
|
CAGR 5-Years
24%
|
CAGR 10-Years
13%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Revenue
AU$11.7m
|
CAGR 3-Years
59%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vita Life Sciences Ltd's Revenue?
Revenue
74.2m
AUD
Based on the financial report for Dec 31, 2023, Vita Life Sciences Ltd's Revenue amounts to 74.2m AUD.
What is Vita Life Sciences Ltd's Revenue growth rate?
Revenue CAGR 10Y
8%
Over the last year, the Revenue growth was 11%. The average annual Revenue growth rates for Vita Life Sciences Ltd have been 17% over the past three years , 13% over the past five years , and 8% over the past ten years .